drugset / Trial / NCT00034450
Developmental Study on Fatigue in Cancer
Phase 2
Completed
140 enrolled
National Center for Complementary and Integrative Health (NCCIH)
National Cancer Institute (NCI) · collabNational Institute of Allergy and Infectious Diseases (NIAID) · collab
RandomizedCrossoverDouble-blindTreatment
Summary
L-carnitine is a supplement (type of vitamin) that has been suggested to be decreased in patients with cancer. We will identify patients that have terminal cancer and fatigue. The purpose of this study is to determine if L-carnitine replacement improves fatigue in cancer patients with L-carnitine deficiency.
Timeline
- Start
- 2002-01
- Primary completion
- —
- Completion
- 2004-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | L-carnitine | Other / unclassified | 2 g | Oral |